Healthcare VCs Foresee AI Transparency Investments, M&A Surges, and Quiet IPOs in 2026

The year 2025 witnessed a remarkable increase in healthcare venture funding, marking a shift in investor interest towards AI startups. Next year, the focus may diverge, with VCs channelling finances into AI companies emphasizing transparent decisions and cost efficiencies.

Last year, investors anticipated large funding rounds for groundbreaking AI startups such as Abridge and Ambience Healthcare. These predictions held true as both companies remarkably secured significant financial backing. As healthcare ventures continue evolving, startup expansions into areas such as medical coding and billing have been intense.

Changing Dynamics in Healthcare AI

As industry giants like Epic enter the foray with new AI solutions for clinical documentation, tensions mount and competition with established partners like Abridge intensifies. As venture capitalists look ahead, they expect shifting dynamics in which healthcare startups secure funding.

Enterprises are pivoting towards models that guarantee cost savings, build trust among patients and providers, and maintain outstanding data quality.

Dan Mendelson from Morgan Health emphasizes that while passive listening and administrative simplification through AI have been achieved, the next goal is to demonstrate financial savings and ease the workload of clinicians and consumers.

M&A Prospects and Behind-the-Scenes AI

While VCs are not forecasting numerous IPOs for 2026, they are optimistic about an active year for mergers and acquisitions within the healthcare landscape. This year, AI startups devoted to administratively heavy tasks within large health systems saw significant funding increases. Companies like Abridge, Ambience Healthcare, and OpenEvidence are expanding their capabilities, but insurance firms might start leveraging AI as a countermeasure.

Todd Cozzens from Transformation Capital notes that larger insurers have already begun collaborating with tech giants like Palantir and Anthropic, with expectations of continuing this trend by adopting highly specialized AI systems to tackle complex healthcare data challenges.

The investment wave will likely favor behind-the-scenes AI models that stress transparency and traceability, as posited by Sapphire Ventures' Cathy Gao. Predicting a move away from inscrutable 'black box' AI, she suggests future healthcare leaders will create transparent, 'glass box' platforms to enhance accountability.

The Resurgence of Tech-Enabled Services

Previously less appealing to venture capitalists, tech startups offering tangible healthcare services may regain popularity. According to Alyssa Jaffee from 7wireVentures, such service models, despite operational costs, could see a renaissance in 2026.

The renewal of these companies may be attributed to the substantial venture capital boost experienced in 2021. Though faced with rigid growth metrics during challenging periods, many emerged stronger, solidifying partnerships with essential clients like health insurers.

Future Exit Strategies

Several healthcare companies are strategizing potential exits for 2026. Virta Health signals its IPO readiness, while PE-backed firms like Zelis Healthcare and Ensemble Health are exploring IPO opportunities. However, the actual filing processes remain largely undisclosed.

Despite tempered expectations for an IPO surge, Michael Greeley from Flare Capital Partners forecasts a surge in acquisition activities, supported by lowered interest rates, heightened liquidity focus, and strategic buyout interests anticipated from private equity.

The trend for merger and acquisition activities witnessed in 2025 continues as firms like New Mountain Capital expand AI acquisitions, with possible buyers including Bain Capital, TPG, Silver Lake, and KKR. Liam Donohue suggests that with the second half of 2026, strategies around public offerings, sales, or competitor mergers will become more active.